mhurhangee/ep-ind-claims huggingface dataset:
An optical scanner which comprises: - an optical source capable of emitting a main optical beam; - at least two elementary scanners, referred to as first (11 1) and second (11 2) scanners respectively, and which comprise: - a first (30 1) and a second beam (30 2) provided, respectively, with a first (36 1) and a second (36 2) movable part on the one hand, and a first and a second fixed parts on the other hand; - a first (40 1) and a second (40 2) actuator arranged to impose flexion or torsion, respectively, to the first and the second movable parts; - a first (70 1) and a second (70 2) optical phased array disposed on or in the first and the second movable parts, respectively, and at which the main optical beam is partly extracted, as a first and a second beam, respectively; the first and second scanners being arranged to scan, along a first AA' and a second BB' direction, by means of the first and second beams, respectively, a first S1 and a second S2 surface, the second surface being of smaller extent than the first surface and included in the first surface. - an optical source capable of emitting a main optical beam; - at least two elementary scanners, referred to as first (11 1) and second (11 2) scanners respectively, and which comprise: - a first (30 1) and a second beam (30 2) provided, respectively, with a first (36 1) and a second (36 2) movable part on the one hand, and a first and a second fixed parts on the other hand; - a first (40 1) and a second (40 2) actuator arranged to impose flexion or torsion, respectively, to the first and the second movable parts; - a first (70 1) and a second (70 2) optical phased array disposed on or in the first and the second movable parts, respectively, and at which the main optical beam is partly extracted, as a first and a second beam, respectively; - a first (30 1) and a second beam (30 2) provided, respectively, with a first (36 1) and a second (36 2) movable part on the one hand, and a first and a second fixed parts on the other hand; - a first (40 1) and a second (40 2) actuator arranged to impose flexion or torsion, respectively, to the first and the second movable parts; - a first (70 1) and a second (70 2) optical phased array disposed on or in the first and the second movable parts, respectively, and at which the main optical beam is partly extracted, as a first and a second beam, respectively;
Operating apparatus in a vehicle, comprising a display apparatus, an elongate capacitive operating element and a control apparatus which is coupled to the display apparatus and the elongate capacitive operating element, wherein the elongate capacitive operating element is subdivided into a plurality of sections (4-1 to 4-7) which are assigned different functional devices of the vehicle and the display apparatus is actuatable by means of the control apparatus in this way, wherein, in the case of capacitive coupling of an actuating object with one of the sections (4-1 to 4-7) of the operating element, a preview for the functional device of the vehicle assigned to this section is presented by the display apparatus when the actuating object remains at the section (4-1 to 4-7) for a defined time interval, characterized in that a plurality of menu entries for a functional device of the vehicle that is assigned to this section are presented by the display apparatus if the actuating object carries out a sliding movement or rotating movement in a defined direction.
A composite resin composition, which comprises, based on 100 parts by weight of components (a) to (f), (a) 10 to 40 parts by weight of a propylene homopolymer resin; (b) 25 to 60 parts by weight of a long glass fiber, which has an average diameter of 10 to 30 μm and an average length of 5 to 20 mm; (c) 0.2 to 15 parts by weight of a modified polyolefin resin, (d) 1 to 15 parts by weight of a polypropylene-based resin selected from the group consisting of an ethylene-propylene block copolymer resin and an ethylene-propylene random copolymer resin; (e) 30 to 50 parts by weight of an ethylene-α-olefin rubber copolymer resin, wherein the copolymer is a copolymer of ethylene and an having 4 to 8 carbon atoms; (f) 0.1 to 10 parts by weight of a polyamide resin; and (g) 500 to 3,000 ppm of a nucleating agent, wherein the propylene homopolymer resin (a) is a mixture of a first propylene homopolymer resin having a melt index of 20 to 40 g/10 minutes and a second propylene homopolymer resin having a melt index of 500 to 1,500 g/10 minutes as measured at 230°C under a load of 2.16 kg, and the mixing ratio of the first propylene homopolymer resin and the second propylene homopolymer resin is 3:7 to 7:3 by weight.
An analyte sensor comprising a channel member, first and second electrodes configured to enable a flow of electrical current from the first electrode through the channel member to the second electrode, and a supporting substrate configured to support the channel member and the first and second electrodes, wherein one or more of the supporting substrate and electrodes (503, 504) are configured such that a portion of the channel member is suspended to expose opposing surfaces (512a,b) of the portion, the exposed opposing surfaces (512a,b) comprising respective functional coatings thereon configured to facilitate variation of the flow of electrical current through the channel member, wherein the functional coating on each of the exposed opposing surfaces (512a,b) comprises a different receptor species configured to interact with a different respective analyte species in the surrounding environment, interaction of the receptor species with the analyte species causing a variation in the electrical current through the channel member.
A method for wireless communication by a base station, BS, comprising: receiving a request, from a user equipment, UE, to participate in at least one of an uplink or a downlink UE positioning procedure; participating in an uplink or a downlink UE positioning procedure with at least one UE in a network based on a request from the at least one UE, the method being characterized by that participating comprises receiving the request using at least one of a message 1, MSG 1, or a message 3, MSG 3, and transmitting a downlink, DL, positioning reference signal, PRS, based on the request whereby the MSG 1 is sent requesting the DL PRS using a physical random access channel, PRACH, and the MSG 3 is sent requesting the DL PRS using a physical uplink shared channel, PUSCH; transmitting an indication that at least one of the uplink or downlink LTE positioning procedure is supported by the base station and other base stations in the network; and transmitting a configuration on-demand for the at least one of the uplink or downlink UE positioning procedure based on the request. receiving a request, from a user equipment, UE, to participate in at least one of an uplink or a downlink UE positioning procedure; participating in an uplink or a downlink UE positioning procedure with at least one UE in a network based on a request from the at least one UE, the method being characterized by that participating comprises receiving the request using at least one of a message 1, MSG 1, or a message 3, MSG 3, and transmitting a downlink, DL, positioning reference signal, PRS, based on the request whereby the MSG 1 is sent requesting the DL PRS using a physical random access channel, PRACH, and the MSG 3 is sent requesting the DL PRS using a physical uplink shared channel, PUSCH; transmitting an indication that at least one of the uplink or downlink LTE positioning procedure is supported by the base station and other base stations in the network; and transmitting a configuration on-demand for the at least one of the uplink or downlink UE positioning procedure based on the request.
A method of epimerizing an -1-benzylisoquinoline alkaloid to an -1-benzylisoquinoline alkaloid within an engineered microbial host cell, comprising: contacting the -1-benzylisoquinoline alkaloid with at least one enzyme comprising an epimerase, wherein contacting the -1-benzylisoquinoline alkaloid with the at least one enzyme converts the -1-benzylisoquinoline alkaloid to an -1-benzylisoquinoline alkaloid within the engineered microbial host cell, wherein the at least one enzyme is produced by culturing the engineered microbial cell having a coding sequence for encoding the at least one enzyme, wherein the -1-benzylisoquinoline alkaloid is contacted with a sufficient amount of said at least one enzyme comprising an epimerase such that at least 5% of the -1-benzylisoquinoline alkaloid is converted to -1-benzylisoquinoline alkaloid, and further wherein: (i) the epimerase has an amino acid sequence with at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% sequence identity to any one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 and 15; or (ii) the epimerase comprises an amino acid sequence selected from the group consisting of: SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and 15. contacting the -1-benzylisoquinoline alkaloid with at least one enzyme comprising an epimerase, wherein contacting the -1-benzylisoquinoline alkaloid with the at least one enzyme converts the -1-benzylisoquinoline alkaloid to an -1-benzylisoquinoline alkaloid within the engineered microbial host cell, wherein the at least one enzyme is produced by culturing the engineered microbial cell having a coding sequence for encoding the at least one enzyme, wherein the -1-benzylisoquinoline alkaloid is contacted with a sufficient amount of said at least one enzyme comprising an epimerase such that at least 5% of the -1-benzylisoquinoline alkaloid is converted to -1-benzylisoquinoline alkaloid, and further wherein: (i) the epimerase has an amino acid sequence with at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% sequence identity to any one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 and 15; or (ii) the epimerase comprises an amino acid sequence selected from the group consisting of: SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and 15. (i) the epimerase has an amino acid sequence with at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% sequence identity to any one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 and 15; or (ii) the epimerase comprises an amino acid sequence selected from the group consisting of: SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and 15.
An apparatus for aftertreatment of exhaust gas comprising: a housing having a longitudinal axis that extends between a first end and a second end of the housing; an exhaust inlet being positioned at a portion of the first end of the housing for entering exhaust gas flow into the interior of the housing; a mixer arrangement being positioned within the interior of the housing downstream to the exhaust inlet and comprising: a first flow guide arrangement configured to guide the exhaust gas flow to rotating and advancing gas flow in a first direction of a crosswise axis perpendicular to the longitudinal axis; a reactant inlet for dispensing reactant to the rotating and advancing gas flow, the reactant configured to mix with the exhaust gas; and a second flow guide arrangement configured to guide the rotating and advancing mixed gas flow in direction of the longitudinal axis as a mixed exhaust gas flow; and a substrate being positioned within the interior of the housing downstream to the mixer arrangement, wherein the mixed exhaust gas flow being configured to flow through the substrate, characterized in that the reactant inlet is configured to dispense reactant in second direction of a crosswise axis perpendicular to the longitudinal axis, the second direction being opposite to the first direction. a housing having a longitudinal axis that extends between a first end and a second end of the housing; an exhaust inlet being positioned at a portion of the first end of the housing for entering exhaust gas flow into the interior of the housing; a mixer arrangement being positioned within the interior of the housing downstream to the exhaust inlet and comprising: a first flow guide arrangement configured to guide the exhaust gas flow to rotating and advancing gas flow in a first direction of a crosswise axis perpendicular to the longitudinal axis; a reactant inlet for dispensing reactant to the rotating and advancing gas flow, the reactant configured to mix with the exhaust gas; and a second flow guide arrangement configured to guide the rotating and advancing mixed gas flow in direction of the longitudinal axis as a mixed exhaust gas flow; and a mixer arrangement being positioned within the interior of the housing downstream to the exhaust inlet and comprising: a first flow guide arrangement configured to guide the exhaust gas flow to rotating and advancing gas flow in a first direction of a crosswise axis perpendicular to the longitudinal axis; a reactant inlet for dispensing reactant to the rotating and advancing gas flow, the reactant configured to mix with the exhaust gas; and a second flow guide arrangement configured to guide the rotating and advancing mixed gas flow in direction of the longitudinal axis as a mixed exhaust gas flow; and a substrate being positioned within the interior of the housing downstream to the mixer arrangement, wherein the mixed exhaust gas flow being configured to flow through the substrate, characterized in that the reactant inlet is configured to dispense reactant in second direction of a crosswise axis perpendicular to the longitudinal axis, the second direction being opposite to the first direction.
A method of depolymerisation of alginic acid, said method comprising the steps of: a) providing alginic acid as a starting material for step b), wherein the alginic acid starting material has a pH in the range of 0-4.4 and wherein the dry matter content of the alginic acid starting material is in the range of 15-70% w/w, and b) treating said alginic acid starting material with microwave irradiation to obtain a depolymerised alginic acid material. a) providing alginic acid as a starting material for step b), wherein the alginic acid starting material has a pH in the range of 0-4.4 and wherein the dry matter content of the alginic acid starting material is in the range of 15-70% w/w, and b) treating said alginic acid starting material with microwave irradiation to obtain a depolymerised alginic acid material.
A method, comprising: receiving electronic label information in a request powered by a connected energy module coupled to an electronic module; displaying the label information at a label, paired to the electronic module, that comprises a display coupled to the electronic module, which label renders images using e-ink, on an industrial automation module such that the label is configurable and provides an image or text without any power by the energy module required to maintain the image or text, wherein the label has a first ID and the method further comprises: receiving a request having a second ID; and comparing the second ID to the first ID; wherein when the second ID matches the first ID, reprogramming the label with the label information in the request characterized in that when the first ID of the label does not match an ID of the electronic module to which it is paired, issuing an alert to a user receiving electronic label information in a request powered by a connected energy module coupled to an electronic module; displaying the label information at a label, paired to the electronic module, that comprises a display coupled to the electronic module, which label renders images using e-ink, on an industrial automation module such that the label is configurable and provides an image or text without any power by the energy module required to maintain the image or text, wherein the label has a first ID and the method further comprises: receiving a request having a second ID; and comparing the second ID to the first ID; wherein when the second ID matches the first ID, reprogramming the label with the label information in the request characterized in that when the first ID of the label does not match an ID of the electronic module to which it is paired, issuing an alert to a user receiving a request having a second ID; and comparing the second ID to the first ID; wherein when the second ID matches the first ID, reprogramming the label with the label information in the request characterized in that when the first ID of the label does not match an ID of the electronic module to which it is paired, issuing an alert to a user
A photosensitive CTP flexographic printing original plate, comprising at least a support, a photosensitive resin layer and a heat-sensitive mask layer which are sequentially layered, characterized in that the heat-sensitive mask layer contains a methoxymethylated polyamide resin and a water-soluble polyamide resin containing a basic nitrogen atom in a molecule, and that a glass transition point of the polyamide resin is 0°C to 30°C.
A system for performing neurophysiologic assessments during surgery, comprising: a stimulator configured to deliver an electrical stimulation signal to a peripheral nerve of a patient, the peripheral nerve exiting the spinal cord inferior to a surgical target site at the patient's spine; at least one sensor configured to detect somatosensory evoked potential data from nervous tissue situated superior to the surgical target site at the patient's spine; and a control unit in communication with the stimulator and the sensor, the control unit being configured to (a) direct transmission of the stimulation signal, (b) receive somatosensory evoked potential data from the sensor, (c) assess spinal cord health by identifying a relationship between the stimulation signal applied to the peripheral nerve and the corresponding somatosensory evoked potential response, and (d) communicate the relationship between the stimulation signal applied to the peripheral nerve and the corresponding somatosensory evoked potential response to a user via alpha-numeric indicia, wherein the alpha-numeric indicia represents a latency value which is the time from delivery of the stimulation signal to the detection of the corresponding somatosensory evoked potential response, characterized in that the alpha-numeric indicia further includes an indicator of a change in latency from a previously acquired baseline measurement. a stimulator configured to deliver an electrical stimulation signal to a peripheral nerve of a patient, the peripheral nerve exiting the spinal cord inferior to a surgical target site at the patient's spine; at least one sensor configured to detect somatosensory evoked potential data from nervous tissue situated superior to the surgical target site at the patient's spine; and a control unit in communication with the stimulator and the sensor, the control unit being configured to (a) direct transmission of the stimulation signal, (b) receive somatosensory evoked potential data from the sensor, (c) assess spinal cord health by identifying a relationship between the stimulation signal applied to the peripheral nerve and the corresponding somatosensory evoked potential response, and (d) communicate the relationship between the stimulation signal applied to the peripheral nerve and the corresponding somatosensory evoked potential response to a user via alpha-numeric indicia, wherein the alpha-numeric indicia represents a latency value which is the time from delivery of the stimulation signal to the detection of the corresponding somatosensory evoked potential response, characterized in that the alpha-numeric indicia further includes an indicator of a change in latency from a previously acquired baseline measurement.
A method for producing an antibody comprising the step of co-cultivating a human, non-mature B-cell with a human CD40L expressing BHK or CHO cell in the presence of IL-2 and IL-21 and IL-6, wherein the cultivation is in the absence of IL-4.
A progesterone antagonist selected from 21-methoxy-17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-4124) or 17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione for use in medical treatment of endometriosis in a patient, according to an intermittent administration regimen comprising administering a therapeutically effective amount of a progesterone antagonist for an administration period during which the progesterone antagonist is administered daily or every other day, over a period of 1, 2, 3, 4, 5, or 6 months, then discontinuing said administration for a discontinuance period by means of a continual lack of treatment with the progesterone antagonist for a period of time sufficient for the female to undergo menstruation, said period of time being less than the number of days during which the progesterone antagonist was previously administered, then administering a therapeutically effective amount of a progesterone antagonist daily or every other day, over a period of 1, 2, 3, 4, 5, or 6 months, then discontinuing said administration by means of a continual lack of treatment with the progesterone antagonist for a period of time sufficient for the female to undergo menstruation, and repeating this treatment of intermittent administration in order to achieve treatment of the endometriosis.
A kit for treating a treatment area in a vasculature, comprising: a first, pre-dilatation catheter having a first shaft including a first distal portion adapted for positioning at the treatment area and a first proximal portion including a first marking at a first location; and a second, dilatation catheter having a second shaft including a second distal portion adapted for positioning at the treatment area and a second proximal portion including a second marking at a second location substantially matching the first location of the first marking, wherein the first and second markings include hash lines forming a ruler with gradations identified by numbers. a first, pre-dilatation catheter having a first shaft including a first distal portion adapted for positioning at the treatment area and a first proximal portion including a first marking at a first location; and a second, dilatation catheter having a second shaft including a second distal portion adapted for positioning at the treatment area and a second proximal portion including a second marking at a second location substantially matching the first location of the first marking, wherein the first and second markings include hash lines forming a ruler with gradations identified by numbers.